Drug companies reach settlement with Ohio counties to avoid federal opioid trial


Just before four drug companies were set to stand trial over their role in the opioid epidemic, a settlement has been reached.
Distributors McKesson Corp., AmerisourceBergen, and Cardinal Health will settle for $215 million with two Ohio counties, with manufacturer Teva Pharmaceuticals also paying $20 million and providing $25 million of anti-addiction medication, The Washington Post reports. This deal came shortly before opening arguments were scheduled to begin in what was to be the first federal opioid trial, the Post notes.
In the case, the plaintiffs had placed blame on the drug companies amid the opioid crisis and argued that "the distributors conspired to flout the federal law that requires them to monitor sales and report outliers," as The New York Times writes. The Monday settlement doesn't include another defendant, Walgreens, and the Post reports its case was postponed. The Ohio counties were seeking $8 billion in the case.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The Wall Street Journal notes that more than 2,300 opioid lawsuits have been brought in federal court, and the settlement announced Monday does "fall short of a more comprehensive deal currently being negotiated to resolve thousands of opioid lawsuits nationwide." Johnson & Johnson previously reached a $20.4 million settlement.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Art review: The Frick Collection
Feature After a $330 million renovation and expansion, New York City's Frick Collection has reopened to the public
-
Amor Towles' 6 favorite books from the 1950s
Feature The author recommends works by Vladimir Nabokov, Jack Kerouac, and more
-
The Supreme Court case that could forge a new path to sue the FBI
The Explainer The case arose after the FBI admitted to raiding the wrong house in 2017
-
Markets notch worst quarter in years as new tariffs loom
Speed Read The S&P 500 is on track for its worst month since 2022 as investors brace for Trump's tariffs
-
Tesla Cybertrucks recalled over dislodging panels
Speed Read Almost every Cybertruck in the US has been recalled over a stainless steel panel that could fall off
-
Crafting emporium Joann is going out of business
Speed Read The 82-year-old fabric and crafts store will be closing all 800 of its stores
-
Trump's China tariffs start after Canada, Mexico pauses
Speed Read The president paused his tariffs on America's closest neighbors after speaking to their leaders, but his import tax on Chinese goods has taken effect
-
Chinese AI chatbot's rise slams US tech stocks
Speed Read The sudden popularity of a new AI chatbot from Chinese startup DeepSeek has sent U.S. tech stocks tumbling
-
US port strike averted with tentative labor deal
Speed Read The strike could have shut down major ports from Texas to Maine
-
Biden expected to block Japanese bid for US Steel
Speed Read The president is blocking the $14 billion acquisition of U.S. Steel by Japan's Nippon Steel, citing national security concerns
-
Judges block $25B Kroger-Albertsons merger
Speed Read The proposed merger between the supermarket giants was stalled when judges overseeing two separate cases blocked the deal